Baird Medical Investment Holdings Limited (BDMD): Honey Is Worth The Money

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) concluded the trading at $8.86 on Friday, January 10 with a rise of 15.82% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $7.65 and 5Y monthly beta was reading 0.142 with its price kept floating in the range of $7.2525 and $9.1471 on the day. Considering stock’s 52-week price range provides that BDMD hit a high price of $13.52 and saw its price falling to a low level of $1.05 during that period. Over a period of past 1-month, stock came adding 406.26% in its value.

With its current market valuation of $314.08 million, Baird Medical Investment Holdings Limited is set to declare its quarterly results in February. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 0 for current year with estimates of that growing to 0 in next year.

Digging deeper we become aware of the PEG ratio of the BDMD stock which is currently positioned at 0. It further provides that stock’s current price level is 148.12% away from its 20-day simple moving average and is 202.37% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 73.49 while volatility remained at 35.28% over the past week which changes to 52.98% when measuring it over the past month. Beta is valued at -0.68, while measure of average true range or ATR is currently at 1.45.

Having a second look at Baird Medical Investment Holdings Limited (NASDAQ:BDMD) provides that stock’s average daily trading volume for 3 months was 1.63 million, while it jumped to 9943780 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 7.29 million.

In December the standing of shares short improved as it was 24534.0 in the previous month. Addition of 16.58% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Most Popular